Even gene drives aimed at controlling malaria-carrying mosquitoes rely on CRISPR’s precision. Among CRISPR’s many variants, the compact Type V Cas12 enzymes—key players in genome editing, diagnostics, ...

The antibiotic polymyxin can pierce the armor of active bacteria, but are ineffective when armor production is shut off in dormant bacteria.

Study in fission yeast revealed a key role for a set of enzymes called agmatinases, which break down the metabolite agmatine into polyamines.

An mRNA vaccine suppressed abnormal blood vessel growth or neovascularization in the retina of AMD mouse models.

This eBook will go beyond just talking about how to streamline manufacturing but also provide in-depth insights into topics that aren’t always covered to the same degree but are just as important to ...

Looking “under the hood” of a cell during chlorate-antibiotic exposure will help investigate how bacteria become susceptible to a range of antibiotics.

CRISPR mouse models show EML4-ALK fusion variants alter drug response, suggesting a need for variant-specific treatment.

Proposed NIH funding cuts are a pressing concern when one considers the broader impacts of reduced research funding.

David Baker’s Nobel Prize-winning lab has designed protein on/off switches as a tool for tunable cancer immunotherapies and biosensors.

Researchers are now exploring how different types of repetitive DNA create genome instability and structurally variant chromosomes.

ADCs can potentially expand the range of effective therapies while minimizing toxicity to healthy tissues, especially in refractory cancer.

IGF2BP3 links cancer metabolism and RNA control, offering a potential new therapeutic target for blocking leukemia cell growth.